Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|20|29|4749-4759
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.20, Iss.29, 2014-01, pp. : 4749-4759
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab: First report of periodontal disease: case report
Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. :
Contribution of Nanotechnology to Improved Treatment of Periodontal Disease
Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. :
Epigenetics and Periodontal Disease: Hope to Tame the Untameable
Current Gene Therapy, Vol. 14, Iss. 6, 2014-12 ,pp. :